 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Checkpoint Systems RFID to overhaul fast-food dining operations in France with roll-out of reusable tableware RFID Technology Checkpoint Systems RFID to overhaul fast-food dining operations in France with roll-out of reusable tableware RFID Technology PR Newswire PHILADELPHIA, July 5, 2023...

Checkpoint Systems RFID to overhaul fast-food dining operations in France with roll-out of reusable tableware RFID Technology

Checkpoint Systems set to showcase new solutions at NRF Protect 2023 Checkpoint Systems set to showcase new solutions at NRF Protect 2023 PR Newswire PHILADELPHIA, May 10, 2023 PHILADELPHIA, May 10, 2023 /PRNewswire/ -- Checkpoint Systems, one of the only vertically integrated RF/RFID solution...

Checkpoint Systems set to showcase new solutions at NRF Protect 2023

---
- Checkpoint reveals new RF label that slashes shrink on metallic items by up to 50%
  Checkpoint reveals new RF label that slashes shrink on metallic items by up to 50%
  PR Newswire THOROFARE, N.J., May 2, 2022 First of its kind security label will enable
  retailers to effectively protect metallic...


Checkpoint reveals new RF label that slashes shrink on metallic items by up to 50%

---
- MIT Technology Review appoints three new Board members, names two co-chairs MIT
  Technology Review appoints three new Board members, names two co-chairs PR Newswire
  CAMBRIDGE, Mass., April 4, 2022 CAMBRIDGE, Mass., April 4, 2022 /PRNewswire/ --
  Today MIT Technology Review announced the recomposition...


MIT Technology Review appoints three new Board members, names two co-chairs

---
- Security labels that balance sales and sustainability Security labels that balance
  sales and sustainability Checkpoint Systems reveals its security labels can be fully
  recycled as part of the household paper-based recycling stream PR Newswire THOROFARE,
  N.J., March 3, 2022 THOROFARE, N.J., March 3...


Security labels that balance sales and sustainability

---
- Checkpoint Announced as a Title Sponsor of the 2022 FMI Asset Protection & Grocery
  Resilience Conference in Orlando Checkpoint Announced as a Title Sponsor of the
  2022 FMI Asset Protection & Grocery Resilience Conference in Orlando March 21-24,
  2022 Join Checkpoint Systems as they...


Checkpoint Announced as a Title Sponsor of the 2022 FMI Asset Protection & Grocery Resilience Conference in Orlando

---
- 'What has Changed in Omnichannel Retail? In 2020: everything. What has Changed in
  Omnichannel Retail? In 2020: everything. Checkpoint Systems takes a closer look
  at what has changed in the omnichannel retail landscape seemingly overnight due
  to the pandemic PR Newswire THOROFARE, N.J., Feb. 12, 2021 ...'


What has Changed in Omnichannel Retail? In 2020: everything.

---
- |-
  In an informed scientific decision, Heat Biologics new lung cancer trial to include checkpoint inhibitors; Long-term vision sees possible increase in efficacy, with toxic side effects reduced; Combining cancer vaccines with checkpoint inhibitors is gaining clinical momentum; Whether both modalities together lead to success hangs in the balance; in the meantime, Heat may need cash; Change in clinical trial design is intended to boost shareholder value through better outcomes

  NEW YORK, NY / ACCESSWIRE / September 18, 2015 / Heat Biologics (HTBX:NASDAQ), in a move motivated by delivering the best clinical results in treatment for non-small cell lung cancer (NSCLC), made an informed scientific move to follow a new initiative.
- Heat is the first to combine a cancer vaccine with a checkpoint inhibitor for NSCLC,
  although others are exploring hopes that a multi-based therapy would increase efficacy
  without bad side effects seen with PD-1 targeted drugs.
- Later, Heat found that patients in its trial for bladder cancer using HS-410 did
  better when low levels of lymphocytes, another key component of human immunity,
  were detected, leading researchers to conclude that cancer vaccines could boost
  T-cell production and, in combination with checkpoint inhibitors, increase the otherwise
  poor numbers of responders with checkpoint inhibitors alone, currently 30%-40% of
  patients.
- With enrollment in DURGA underway, Heat is ahead of NewLink as the first biotech
  to use a vaccine with a checkpoint inhibitor in lung cancer.
- Heat viewed this as support for shifting clinical focus in its NSCLC trial and in
  addition to Opdivo, plans to study Merck & Co.'s (MRK:NYSE) Keytruda, another potent
  checkpoint inhibitor, with HS-110 when Keytruda gets approval for lung cancer (Keytruda
  received Breakthrough Therapy designation from the FDA last October, stressing clinical
  recognition of the strength of this drug class).


52-Wk High	$0.00
52-Wk Low	$0.00

CKP Checkpoint Systems Inc.

About

Feed

News

Fundamentals